Non-Hodgkin's lymphoma and hepatitis C virus: A case-control study from northern and southern Italy

International Journal of Cancer

Volumn 110, Issue 3, 2004, Pages 380-385

  Talamini, Renato ^a   Montella, Maurizio ^b   Crovatto, Marina ^c   Dal Maso, Luigino ^a   Cpispo, Anna ^b   Negri, Eva ^d   Spina, Michele ^a   Pinto, Antonio ^b   Carbone, Antonino ^a   Franceschi, Silvia ^e  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c S MARIA DEGLI ANGELI HOSPITAL   (Italy)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Case control study; Hepatitis B virus; Hepatitis C virus; Non Hodgkin's lymphoma

Indexed keywords

VIRUS RNA;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CANCER GRADING; CANCER RISK; CARCINOGENESIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; ITALY; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; QUESTIONNAIRE; TATTOO; TOOTH EXTRACTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DNA, VIRAL; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; ITALY; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED;

EID: 2442419813     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20137     Document Type: Article

References (42)

1. Dubois F, Desenclos JC, Mariotte N, Goudeau A. Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. The Collaborative Study Group. Hepatology 1997;25:1490-6.
2. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-62.
3. Goritsas C, Plerou I, Agaliotis S, Spinthaki R, Mimidis K, Velissaris D, Lazarou N, Labropoulou-Karatza C. HCV infection in the general population of a Greek island: prevalence and risk factors. Hepatogastroenterology 2000;47:782-5.
4. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, El Khoby T, Abdel-Wahab Y, Aly Ohn ES, Anwar W, Sallam I. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000;355:887-91.
5. Guadagnino V, Stroffolini T, Rapicetta M, Costantino A, Kondili LA, Menniti-Ippolito F, Caroleo B, Costa C, Griffo G, Loiacono L, Pisani V, Foca A, et al. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology 1997;26:1006-11.
6. Montella M, Crispo A, Serraino D, Rezza G, Franceschi S. Is the spread of HCV in southern Italy attributable to iatrogenic transmission through unsterile injections? Eur J Cancer Prev 2003;12:85-6.
7. Shin HR, Kim JY, Kim JI, Lee DH, Yoo KY, Lee DS, Franceschi S. Hepatitis B and C virus prevalence in a rural area of South Korea: the role of acupuncture. Br J Cancer 2002;87:314-8.
8. Kiyosawa K, Tanaka E, Sodeyama T, Yoshizawa K, Yabu K, Furuta K, Imai H, Nakano Y, Usuda S, Uemura K, Furuta S, Watanabe Y, et al. Transmission of hepatitis C in an isolated area in Japan: community-acquired infection. The South Kiso Hepatitis Study Group. Gastroenterology 1994;106:1596-602.
9. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001;345:41-52.
10. Domingo JM, Romero S, Moreno JA, Domingo JA, Callen L, Gutierrez M. Hepatitis C virus infection and mixed cryoglobulinemia in patients with lymphoproliferative diseases. Haematologica 1999;84:94-6.
11. Montella M, Crispo A, Russo F, Ronga D, Tridente V, Tamburini M. Hepatitis C virus infection and a new association with extrahepatic disease: multiple myeloma. Haematologica 2000;85:883-4.
12. Gasparotto D, De Re V, Boiocchi M. Hepatitis C virus, B-cell proliferation and lymphomas. Leuk Lymphoma 2002;43:747-51.
13. Negri E, Little D'A, Boiocchi M, La Vecchia C, Franceschi S. B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review of 66 studies. Int J Cancer, in press.
14. De Vita S, Zagonel V, Russo A, Rupolo M, Cannizzaro R, Chiara G, Boiocchi M, Carbone A, Franceschi S. Hepatitis C virus, non-Hodgkin's lymphomas and hepatocellular carcinoma. Br J Cancer 1998;77:2032-5.
15. Montella M, Crispo A, Frigeri F, Ronga D, Tridente V, De Marco M, Fabbrocini G, Spada O, Mettivier V, Tamburini M. HCV and tumors correlated with immune system: a case-control study in an area of hyperendemicity. Leuk Res 2001;25:775-81.
16. Mele A, Pulsoni A, Bianco E, Musto P, Szklo A, Sanpaolo MG, Iannitto E, De Renzo A, Martino B, Liso V, Andrizzi C, Posterla S, et al. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multi-centre case-control study. Blood 2003;102:996-9.
17. Zuckerman E, Zuckerman T, Levine AM, Douer D, Gutekunst K, Mizokami M, Qian DG, Velankar M, Nathwani BN, Fong TL. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997;127:423-8.
18. Ohsawa M, Shingu N, Miwa H, Yoshihara H, Kubo M, Tsukuma H, Teshima H, Hashimoto M, Aozasa K. Risk of non-Hodgkin's lymphoma in patients with hepatitis C virus infection. Int J Cancer 1999;80:237-9.
19. Imai Y, Ohsawa M, Tanaka H, Tamura S, Sugawara H, Kuyama J, Fukuda K, Yonezawa T, Matsuzawa Y, Matszawa Y. High prevalence of HCV infection in patients with B-cell non-Hodgkin's lymphoma: comparison with birth cohort- and sex-matched blood donors in a Japanese population. Hepatology 2002;35:974-6.
20. Collier JD, Zanke B, Moore M, Kessler G, Krajden M, Shepherd F, Heathcote J. No association between hepatitis C and B-cell lymphoma. Hepatology 1999;29:1259-61.
21. Rabkin CS, Tess BH, Christianson RE, Wright WE, Waters DJ, Alter HJ, Van Den Berg BJ. Prospective study of hepatitis C viral infection as a risk factor for subsequent B-cell neoplasia. Blood 2002;99:4240-2.
22. El-Serag HB, Hampel H, Rabencek L. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology 2002;36:1439-45.
23. Kim JH, Bang Y-J, Park BJ, Yoo T, Kim CW, Kim TY, Heo DS, Lee HS, Kim NK. Hepatitis B virus infection and B-cell non-Hodgkin's lymphoma in a hepatitis B endemic area: a case-control study. Jpn J Cancer Res 2002;93:471-7.
24. Levi F, Lucchini F, Negri E, La Vecchia C. Trends in mortality from non-Hodgkin's lymphomas. Leuk Res 2002;26:903-8.
25. Bellentani S, Tiribelli C, Saccoccio G, Sodde M, Fratti N, De Martin C, Cristianini G, Dionysos Study Group. Prevalence of chronic liver disease in the general population of northern Italy: The Dionysos Study. Hepatology 1994;20:1442-9.
26. Percy C, Van Holten V, Muir C. International classification of diseases for oncology, ICD-O, 2nd ed. Geneva: WHO, 1990.
27. Harris NL, Jaffe ES, Stein J, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
28. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organisation classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC, 2001.
29. Colin C, Lanoir D, Touzet S, Meyaud-Kraemer L, Bailly F, Trepo C. Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: an analysis of the literature. J Viral Hepatol 2001;8:87-95.
30. Breslow NE, Day NE. Statistical methods in cancer research. vol. I. The analysis of case-control studies. IARC Sci Publ 32. Lyon: IARC, 1980.
31. Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C. Estimating the population attributable risk for multiple risk factor using case-control data. Am J Epidemiol 1985;122:904-14.
32. Silvestri F, Barillari G, Fanin R, Pipan C, Falasca G, Salmaso F, Zaja F, Infanti L, Patriarca F, Botta GA, Baccarani M. The genotype of the hepatitis C virus in patients with HCV-related B cell non-Hodgkin's lymphoma. Leukemia 1997;11:2157-61.
33. Hermine O, Lefrère F, Bronowicki J-P, Mariette X, Jondeau K, Eclache-Saudreau V, Delmas B, Valensi F, Cacoub P, Brechot C, Varet B, Troussard X. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002;347:89-94.
34. Silvestri F, Barillari G, Fanin R, Pipan C, Falasca E, Salmaso F, Zaja F, Infanti L, Patriarca F, Botta GA, Baccarani M. Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin's lymphomas. Haematologica 1997;82:314-7.
35. Germanidis G, Haloun C, Pourquier J, Gaulard P, Pawlotsky JM, Dhumeaux D, Reyes F. Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a French center. Blood 1999;93:1778-9.
36. Pagano JS. Viruses and lymphomas. N Engl J Med 2002;347:78-9.
37. Kuppers R, Klein U, Hansmann M-L, Rajewsky K. Cellular origin of human B-cell lymphomas. N Engl J Med 1999;341:1520-9.
38. Engels EA, Frisch M, Lubin JH, Gail MH, Biggar RJ, Goedert JJ. Prevalence of hepatitis C virus infection and risk for hepatocellular carcinoma and non-Hodgkin lymphoma in AIDS. J Acquir Immune Defic Syndr 2002;31:536-41.
39. Kuniyoshi M, Nakamuta M, Sakai H, Enjoji M, Kinukawa N, Kotoh K, Fukutomi M, Yokota M, Nishi H, Iwamoto H, Uike N, Nishimura J, et al. Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma. J Gastroenterol Hepatol 2001;16:215-9.
40. Kawai Y, Ikegaya S, Hata M, Kawahito M, Imamura S, Yoshida A, Tsutani H, Ueda T. Successful lamivudine therapy for post-chemotherapeutic fulminant hepatitis B in a hepatitis B virus carrier with non-Hodgkin's lymphoma: case report and review of the literature. Ann Hematol 2001;80:482-4.
41. Alexander FE. Blood transfusion and risk of non-Hodgkin lymphoma. Lancet 1997;350:1414-5.
42. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-50.